Lipocine (STU:2VT0) 9-Day RSI: N/A (As of Jul. 06, 2026)


STU:2VT0 Lipocine Inc STU:2VT0
52 GF Score
Price €3.94
GF Value €3.10
! 4 Warning Signs
View Full Analysis

What is Lipocine 9-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-06), Lipocine's 9-Day RSI is N/A.

The industry rank for Lipocine's 9-Day RSI or its related term are showing as below:

STU:2VT0's 9-Day RSI is not ranked *
in the Biotechnology industry.
Industry Median: 53.705
* Ranked among companies with meaningful 9-Day RSI only.

Lipocine  (STU:2VT0) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Lipocine 9-Day RSI Related Terms


STU:2VT0 vs NCEL, PTN, ALLR: 9-Day RSI Comparison

For the Biotechnology subindustry, Lipocine's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipocine 9-Day RSI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipocine's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Lipocine's 9-Day RSI falls into.


STU:2VT0
52GF Score
Lipocine Inc STU:2VT0
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lipocine  (STU:2VT0) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Lipocine (STU:2VT0) Overvalued in 2026?

Based on GuruFocus' analysis, Lipocine stock appears to be overvalued. The current stock price of €3.94 is trading 27.2% above its estimated GF Value™ of €3.10.

Key valuation signals for STU:2VT0:

  • 9-Day RSI: N/A
  • GF Value™: €3.10 vs. price of €3.94 (27.2% above fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the STU:2VT0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lipocine Business Description

Other Exchanges LPCN:USA
Address 675 Arapeen Drive, Suite 202, Salt Lake City, UT, USA, 84108
Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
52GF Score

Get the complete analysis for STU:2VT0

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.94
Price
€3.10
GF Value